Psoriasis is a chronic inflammatory skin disorder, and current treatments include topical
therapies, phototherapy, systemic immune modulators, and biologics, aiming to alleviate …

Nanoparticle-based drug carriers are being pursued intensely to overcome the skin barrier
and improve even hydrophilic or macromolecular drug delivery into or across the skin …

Nanoparticle (NP) is an emerging tool applied in the biomedical field. With combination of
different materials and adjustment of their physical and chemical properties, nanoparticles …

Neutrophil granulocytes, or neutrophils, are the most abundant circulating leukocytes in
humans and indispensable for antimicrobial immunity, as exemplified in patients with inborn …

Immune responses are involved in the pathogenesis of many diseases, including cancer,
autoimmune diseases, and chronic inflammation. These responses are attributed to immune …

Conventional immunosuppressants cause side effects and do not prevent the recurrence of
autoimmune diseases. Moreover, they may not inhibit autoimmunity mediated by pathogenic …

Psoriasis does not respond adequately to the monotherapy, tailoring combined strategies for
synergistical treatment remains challenging. We fabricated chitosan/hyaluronan nanogels to …

Background Psoriasis is a chronic relapsing immunological skin disease characterized by
multiple cross-talk inflammatory circuits which are relevantly associated with abnormal cross …

Inflammatory diseases are key contributors to high mortality globally and adversely affect the
quality of life. Current treatments include corticosteroids or nonsteroidal anti-inflammatories …

Psoriasis is a chronic inflammatory skin disease with dysregulation of the immune system,
which usually manifests as erythematous scleroma with hyperplasia of the epidermis …